A comparison study of realtime fatality rates: severe acute respiratory syndrome in Hong Kong, Singapore, Taiwan, Toronto and Beijing, China

Summary.  In an outbreak of a completely new infectious disease like severe acute respiratory syndrome (SARS), estimation of the fatality rate over the course of the epidemic is of clinical and epidemiological importance. In contrast with the constant case fatality rate, a new measure, termed the ‘realtime’ fatality rate, is proposed for monitoring the new emerging epidemic at a population level. A competing risk model implemented via a counting process is used to estimate the realtime fatality rate in an epidemic of SARS. It can capture and reflect the time‐varying nature of the fatality rate over the course of the outbreak in a timely and accurate manner. More importantly, it can provide information on the efficacy of a certain treatment and management policy for the disease. The method has been applied to the SARS data from the regions affected, namely Hong Kong, Singapore, Toronto, Taiwan and Beijing. The magnitudes and patterns of the estimated fatalities are virtually the same except in Beijing, which has a lower rate. It is speculated that the effect is linked to the different treatment protocols that were used. The standard estimate of the case fatality rate that was used by the World Health Organization has been shown to be unable to provide useful information to monitor the time‐varying fatalities that are caused by the epidemic.

[1]  A. Danchin,et al.  The Severe Acute Respiratory Syndrome , 2003 .

[2]  Kow-Tong Chen,et al.  Control Measures for Severe Acute Respiratory Syndrome (SARS) in Taiwan , 2003, Emerging infectious diseases.

[3]  J. Peiris,et al.  Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS) , 2003, The Lancet.

[4]  C. Fraser,et al.  Transmission Dynamics of the Etiological Agent of SARS in Hong Kong: Impact of Public Health Interventions , 2003, Science.

[5]  H. Doerr,et al.  Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus , 2003, The Lancet.

[6]  W. Lam,et al.  Management of severe acute respiratory syndrome: the Hong Kong University experience. , 2003, American journal of respiratory and critical care medicine.

[7]  C. Fraser,et al.  Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong , 2003, The Lancet.

[8]  Y. Leo,et al.  Severe Acute Respiratory Syndrome (SARS) in Singapore: Clinical Features of Index Patient and Initial Contacts , 2003, Emerging infectious diseases.

[9]  Elizabeth Rea,et al.  Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. , 2003, JAMA.

[10]  Michael B Edmond,et al.  Managing SARS amidst uncertainty. , 2003, The New England journal of medicine.

[11]  Christian Drosten,et al.  Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.

[12]  S. Lapinsky,et al.  ICU management of severe acute respiratory syndrome , 2003, Intensive Care Medicine.

[13]  Niels Keiding,et al.  Statistical Models Based on Counting Processes , 1993 .

[14]  H. Ramlau-Hansen.  Smoothing Counting Process Intensities by Means of Kernel Functions , 1983 .

[15]  D. Cyranoski.  Critics slam treatment for SARS as ineffective and perhaps dangerous , 2003, Nature.

[16]  M. Chan-yeung,et al.  A cluster of cases of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.

[17]  P. Yip,et al.  A class of non-parametric tests for the equality of failure rates in a competing risks model , 1992 .

[18]  Peter Cameron,et al.  A major outbreak of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.

[19]  P. Yip,et al.  A multivariate nonparametric test for the equality of failure rates in a competing risks model , 1993 .

[20]  J. Chan,et al.  Severe acute respiratory syndrome (SARS) , 2003, British journal of haematology.

[21]  G. Ooi,et al.  Severe acute respiratory syndrome (SARS) in Hong Kong , 2003, Respirology.

[22]  L. Poon,et al.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .